Pharvaris (PHVS)
(Real Time Quote from BATS)
$19.20 USD
-0.31 (-1.59%)
Updated Sep 23, 2024 01:52 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Income Statements
Fiscal Year end for Pharvaris NV falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | NA |
Cost Of Goods | 0 | 0 | 0 | 0 | NA |
Gross Profit | 0 | 0 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 105 | 91 | 64 | 29 | 0 |
Income After Depreciation & Amortization | -105 | -91 | -64 | -29 | 0 |
Non-Operating Income | 0 | 0 | 0 | 0 | NA |
Interest Expense | 3 | -12 | -14 | 1 | NA |
Pretax Income | -108 | -80 | -50 | -30 | NA |
Income Taxes | 1 | 1 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -109 | -80 | -51 | -30 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -109 | -80 | -51 | -30 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -105 | -91 | -64 | -29 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | -105 | -91 | -64 | -29 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 38.39 | 33.61 | 30.41 | 4.85 | NA |
Diluted EPS Before Non-Recurring Items | -2.84 | -2.39 | -1.66 | -6.12 | NA |
Diluted Net EPS (GAAP) | -2.85 | -2.39 | -1.66 | -6.12 | NA |
Fiscal Year end for Pharvaris NV falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 37.02 | 30.74 | 29.27 | 28.51 | 24.49 |
Income After SG&A, R&D, and Dept/Amort Expenses | -37.02 | -30.74 | -29.27 | -28.51 | -24.49 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | -5.08 | -0.63 | 5.25 | -2.99 | -0.71 |
Pretax Income | -31.94 | -30.11 | -34.51 | -25.53 | -23.77 |
Income Taxes | 0.08 | 0.31 | 0.81 | 0.16 | 0.10 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -32.02 | -30.42 | -35.32 | -25.68 | -23.88 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -32.02 | -30.42 | -35.32 | -25.68 | -23.88 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 54.06 | 53.88 | 44.25 | 40.69 | 34.56 |
Diluted EPS Before Non-Recurring Items | -0.59 | -0.56 | -0.80 | -0.63 | -0.69 |
Diluted Net EPS (GAAP) | -0.59 | -0.56 | -0.81 | -0.63 | -0.69 |